Diomed Announces Record Second Quarter EVLT Revenue Growth; Company Delivers 50% Growth In Total Revenues And 94% Increase In North American EVLT Sales

ANDOVER, Mass.--(BUSINESS WIRE)--July 28, 2005--Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its patented EVLT(R) laser treatment for varicose veins, today announced results for the second quarter ended June 30, 2005. Diomed delivered total revenue of $4.8 million for the quarter ended June 30, 2005, an increase of $1.6 million, or 50% compared to the same quarter of 2004, while EVLT(R) revenue increased 69%.
MORE ON THIS TOPIC